Home
 
Sitemap
 
Legal Statement
 
 
 
 
 
 
 
 
 
Home > Products > Tracleer® > > About Tracleer > Haemodynamics
 
Products
 
 
 
 
 
 
 
 
 
 
Tracleer®
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
About PAH
 
 
 
 
 
 
 
 
 
 
 
 
Clinical worsening
 
 
Exercise capacity
 
Haemodynamics
 
 
Special patient population
 
 
Dosing regimen
 
 
WHO functional class
 
 
Long-term outcomes
 
 
Safety information
 
 
Effective patient management
 
 
References
 
 
Links of Interest
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Zavesca®
 
 
 
Impact on Haemodynamics

  • The functional improvement observed with Tracleer® is supported by corresponding improvements in key haemodynamic measures, CI, PVR, mPAP and RAP (figure 10)3

Figure 10: Tracleer significantly improves key haemodynamic measures3



Last update: 11 Jul 2008